Oki Mark K 4/A
4/A · AYTU BIOPHARMA, INC · Filed Nov 28, 2022
Insider Transaction Report
Form 4/AAmended
Oki Mark K
Chief Financial Officer
Transactions
- Purchase
Common Shares
2022-11-18$0.23/sh+90,000$20,700→ 190,000 total
4/A · AYTU BIOPHARMA, INC · Filed Nov 28, 2022
Common Shares